Please turn JavaScript on
READ
PUBLISH
My newsFind FeedsDelivery settingsPlansMy earnings
HelpBlog
Login
Find more feeds
header-image

Boston Biotech Clinical Research

Want to know the latest news and articles posted on Boston Biotech Clinical Research?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Boston Biotech Clinical Research

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.19 / week

Message History

BBCR partners with clients to identify, develop, and advance a product’s unique strengths from early concept through...

BBCR partners with sponsors and investors to navigate complex paths to market, strengthening product potential while advancing efficiency and safety. Through strategic expertise and early clinical research services, we support informed, timely decisions at every stage of development. Learn more about the services we provide within the areas of Early Clinical Research and ...


Read full story
BBCR’s team of experts help clients match treatments to rare genetic conditions and unsolved diseases, then work col...

Did you know that about a third of orphan approvals by the FDA since the program began have been mostly for repurposed mass-market drugs? Drug repurposing acts to lower the need for early stage clinical trials and can help identify new uses for existing drugs. We invite you to learn more about how BBCR can […]


Read full story
Drug repurposing accelerates the path from discovery to the clinic, offering particular promise for rare, neglected,...

The BBCR consultants, experienced in orphan, rare and ultra-rare diseases, have advised biotech and venture capitalists for new indications evaluation and prioritization. BBCR’s team of industry experts can help match treatments to rare genetic conditions and unsolved diseases, then work with a product developer on the best plan to market. Candidate assessment for 505(b)(...


Read full story
Is Your Drug Development Strategy Built for Tomorrow’s Success?

With BBCR’s Strategic Clinical Innovation Organization (SCIO℠) method, we’re redefining how innovation meets efficiency in drug development—providing a clear, data-driven path to market approval. The SCIO℠ method works by learning and predicting—analyzing each pre-clinical asset to identify its true potential and forecasting the level of certainty for every strategic opti...


Read full story
BBCR assists companies with the identification and adoption of biomarkers, now a routine part of drug development, a...

The FDA recognizes biomarker development as a high priority area for future research. BBCR can help your company with your product development plan and validation. BBCR is dedicated to supporting pharmaceutical innovators in the specialized rare diseases and orphan drug indications by developing and nurturing the product’s unique strengths. It is our team’s operational mi...


Read full story